CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd (CLGN) Implied Volatility Current
CLGN's 30 day implied volatility is 616.50%, with an IV Rank of 71.03%. This is a high IV Rank versus the past year, meaning CollPlant Biotechnologies Ltd options are relatively expensive and currently favor sellers. CLGN's 30 day historical volatility sits at 116.68%, which means implied volatility is running 499.82 points above historical volatility, as of Nov 16, 2026.
Read more
Tracking CLGN implied volatility helps you spot when CollPlant Biotechnologies Ltd options are historically cheap or expensive, and where the best trades are hiding. When CLGN IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor CLGN implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking CLGN IV rank helps you see whether CLGN's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds.
Implied Volatility
IV is highly elevated. Premiums are expensive, strongly favoring sellers.
As of Nov 16, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →